+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Allergic Rhinitis Treatment Market: By Disease Type By Treatment Drugs Type & Geography - Forecast 2016-2021

  • ID: 3820833
  • Report
  • 132 pages
  • IndustryARC
1 of 2
Allergic rhinitis is commonly known as Hay fever, caused by some of the typical allergens namely pollen, grass, dust, animal dander, cat saliva and mold. Apart from this common allergens some of the other major factors responsible for the disease are cigarette smoke, chemicals, cold temperatures, humidity, wind, air pollution, hairspray, perfumes & colognes, wood smoke, and fumes. This is the most common allergic disease found in majority of the countries with a prevalence range of between 2 to 40% in various countries across the globe. Allergic rhinitis refers to a chronic inflammatory disease affecting the nasal cavity identified by some of the common symptoms such as Nasal itching, sore throat, runny or blocked nose, and sneezing are some of the characteristic symptoms of allergic rhinitis.

Globally demand for allergic rhinitis treatment market is driven by factors such as increasing awareness amongst people about disease and increasing number of respiratory problems related cases due to increasing pollution and tobacco consumption.

This report identifies the allergic rhinitis treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to allergic rhinitis treatment market.

Globally demand for allergic rhinitis treatment is expected to witness growth in the upcoming future due to increasing respiratory disease globally. North America represents highest market share in the global allergic rhinitis treatment market as reported cases for allergic rhinitis is highest in the U.S. followed by Europe with the second highest market share amongst all the major regions.

This report on allergic rhinitis treatment has been divided based on disease type, which is segmented as: Perennial allergic rhinitis and Seasonal allergic rhinitis
Allergic rhinitis treatment market is further also segmented based on the available treatments which includes major treatment namely: Antihistamines, Intranasal corticosteroids, Immunotherapies, Decongestants and others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the Allergic Rhinitis market. Some of the major companies’ profiles in detail are as follows:

Meda Pharmaceuticals
Dr Reddy's Laboratories
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Allergic Rhinitis Treatment – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Allergic Rhinitis Treatment – Market Forces
4.1. Drivers
4.1.1. Increasing number of tobacco consumers globally
4.1.2. Increasing number of respiratory diseases cases globally
4.2. Restraints
4.2.1. Lower awareness amongst large part of human population
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Allergic Rhinitis Treatment Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Global Allergic Rhinitis Treatment Market, By Disease Type (2014-2021)
6.1. Seasonal Allergic Rhinitis
6.2. Perenial Allergic Rhinitis

7. Global Allergic Rhinitis Treatment Market, By Treatment Drugs Type (2014-2021)
7.1. Antihistamines
7.2. Intranasal corticosteroids
7.3. Immunotherapies
7.4. Decongestants
7.5. Others

8. Global Allergic Rhinitis Treatment Market, By Geography (2014-2021)
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Allergic Rhinitis Treatment – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Top 10 Companies)
10.1. GlaxoSmithKline
10.1.1. Introduction
10.1.2. Financials
10.1.3. Key Insights
10.1.4. Key Strategy
10.1.5. Product Portfolio
10.1.6. SWOT Analysis
10.2. Sanofi
10.2.1. Introduction
10.2.2. Financials
10.2.3. Key Insights
10.2.4. Key Strategy
10.2.5. Product Portfolio
10.2.6. SWOT Analysis
10.3. AstraZeneca
10.3.1. Introduction
10.3.2. Financials
10.3.3. Key Insights
10.3.4. Key Strategy
10.3.5. Product Portfolio
10.3.6. SWOT Analysis
10.4. Meda Pharmaceuticals
10.4.1. Introduction
10.4.2. Financials
10.4.3. Key Insights
10.4.4. Key Strategy
10.4.5. Product Portfolio
10.4.6. SWOT Analysis
10.5. Dr Reddy's Laboratories
10.5.1. Introduction
10.5.2. Financials
10.5.3. Key Insights
10.5.4. Key Strategy
10.5.5. Product Portfolio
10.5.6. SWOT Analysis
10.6. Pfizer
10.6.1. Introduction
10.6.2. Financials
10.6.3. Key Insights
10.6.4. Key Strategy
10.6.5. Product Portfolio
10.6.6. SWOT Analysis
10.7. Novartis
10.7.1. Introduction
10.7.2. Financials
10.7.3. Key Insights
10.7.4. Key Strategy
10.7.5. Product Portfolio
10.7.6. SWOT Analysis
10.8. Sun Pharmaceuticals
10.8.1. Introduction
10.8.2. Financials
10.8.3. Key Insights
10.8.4. Key Strategy
10.8.5. Product Portfolio
10.8.6. SWOT Analysis
10.9. UCB S.A.
10.9.1. Introduction
10.9.2. Financials
10.9.3. Key Insights
10.9.4. Key Strategy
10.9.5. Product Portfolio
10.9.6. SWOT Analysis
10.10. Atopix Therapeutics
10.10.1. Introduction
10.10.2. Financials
10.10.3. Key Insights
10.10.4. Key Strategy
10.10.5. Product Portfolio
10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 2